Last updated on May 2020

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis


Brief description of study

The study will investigate the efficacy and safety of an oral dose of AJM300 960 milligram (mg)/dose administered three times daily for 8 weeks in participants with active ulcerative colitis.

Clinical Study Identifier: NCT03531892

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.